179 related articles for article (PubMed ID: 1458340)
1. Isolation and characterization of human embryonic osteoblasts.
Oliva A; Marrone G; Della Ragione F; Riccio V; Palumbo R; Rossano F; Zappia V
Calcif Tissue Int; 1992 Nov; 51(5):356-62. PubMed ID: 1458340
[TBL] [Abstract][Full Text] [Related]
2. Vitamin K2 promotes 1alpha,25(OH)2 vitamin D3-induced mineralization in human periosteal osteoblasts.
Koshihara Y; Hoshi K; Ishibashi H; Shiraki M
Calcif Tissue Int; 1996 Dec; 59(6):466-73. PubMed ID: 8939773
[TBL] [Abstract][Full Text] [Related]
3. Subcloning of three osteoblastic cell lines with distinct differentiation phenotypes from the mouse osteoblastic cell line KS-4.
Yamashita T; Ishii H; Shimoda K; Sampath TK; Katagiri T; Wada M; Osawa T; Suda T
Bone; 1996 Nov; 19(5):429-36. PubMed ID: 8922640
[TBL] [Abstract][Full Text] [Related]
4. Model for in vitro investigation of bone mineralization.
Ecsedi GG
Agents Actions; 1994 Mar; 41(1-2):84-5. PubMed ID: 8079826
[TBL] [Abstract][Full Text] [Related]
5. Stimulation by 1,25-dihydroxyvitamin D3 of in vitro mineralization induced by osteoblast-like MC3T3-E1 cells.
Matsumoto T; Igarashi C; Takeuchi Y; Harada S; Kikuchi T; Yamato H; Ogata E
Bone; 1991; 12(1):27-32. PubMed ID: 2054233
[TBL] [Abstract][Full Text] [Related]
6. Cultures of human embryonic osteoblasts. A new in vitro model for biocompatibility studies.
Riccio V; Della Ragione F; Marrone G; Palumbo R; Guida G; Oliva A
Clin Orthop Relat Res; 1994 Nov; (308):73-8. PubMed ID: 7955704
[TBL] [Abstract][Full Text] [Related]
7. Differentiation of heterogeneous phenotypes in human osteoblast cultures in response to 1,25-dihydroxyvitamin D3.
Thavarajah M; Evans DB; Kanis JA
Bone; 1993; 14(5):763-7. PubMed ID: 7505605
[TBL] [Abstract][Full Text] [Related]
8. Effects of methotrexate on human osteoblasts in vitro: modulation by 1,25-dihydroxyvitamin D3.
Scheven BA; van der Veen MJ; Damen CA; Lafeber FP; Van Rijn HJ; Bijlsma JW; Duursma SA
J Bone Miner Res; 1995 Jun; 10(6):874-80. PubMed ID: 7572311
[TBL] [Abstract][Full Text] [Related]
9. Maturation state determines the response of osteogenic cells to surface roughness and 1,25-dihydroxyvitamin D3.
Lohmann CH; Bonewald LF; Sisk MA; Sylvia VL; Cochran DL; Dean DD; Boyan BD; Schwartz Z
J Bone Miner Res; 2000 Jun; 15(6):1169-80. PubMed ID: 10841186
[TBL] [Abstract][Full Text] [Related]
10. The influence of type I collagen on the development and maintenance of the osteoblast phenotype in primary and passaged rat calvarial osteoblasts: modification of expression of genes supporting cell growth, adhesion, and extracellular matrix mineralization.
Lynch MP; Stein JL; Stein GS; Lian JB
Exp Cell Res; 1995 Jan; 216(1):35-45. PubMed ID: 7813631
[TBL] [Abstract][Full Text] [Related]
11. Production and action of transforming growth factor-beta in human osteoblast cultures: dependence on cell differentiation and modulation by calcitriol.
Kassem M; Kveiborg M; Eriksen EF
Eur J Clin Invest; 2000 May; 30(5):429-37. PubMed ID: 10809903
[TBL] [Abstract][Full Text] [Related]
12. Evidence that both 1alpha,25-dihydroxyvitamin D3 and 24-hydroxylated D3 enhance human osteoblast differentiation and mineralization.
van Driel M; Koedam M; Buurman CJ; Roelse M; Weyts F; Chiba H; Uitterlinden AG; Pols HA; van Leeuwen JP
J Cell Biochem; 2006 Oct; 99(3):922-35. PubMed ID: 16741965
[TBL] [Abstract][Full Text] [Related]
13. Mouse embryo-derived NIH3T3 fibroblasts adopt an osteoblast-like phenotype when treated with 1alpha,25-dihydroxyvitamin D(3) and dexamethasone in vitro.
Shui C; Scutt AM
J Cell Physiol; 2002 Nov; 193(2):164-72. PubMed ID: 12384993
[TBL] [Abstract][Full Text] [Related]
14. Mineralization of three-dimensional osteoblast cultures is enhanced by the interaction of 1α,25-dihydroxyvitamin D3 and BMP2 via two specific vitamin D receptors.
Chen J; Dosier CR; Park JH; De S; Guldberg RE; Boyan BD; Schwartz Z
J Tissue Eng Regen Med; 2016 Jan; 10(1):40-51. PubMed ID: 23784946
[TBL] [Abstract][Full Text] [Related]
15. Development of the osteoblast phenotype in primary human osteoblasts in culture: comparison with rat calvarial cells in osteoblast differentiation.
Siggelkow H; Rebenstorff K; Kurre W; Niedhart C; Engel I; Schulz H; Atkinson MJ; Hüfner M
J Cell Biochem; 1999 Oct; 75(1):22-35. PubMed ID: 10462701
[TBL] [Abstract][Full Text] [Related]
16. Variable hormone responsiveness of osteoblast populations isolated at different stages of embryogenesis and its relationship to the osteogenic lineage.
Gerstenfeld LC; Zurakowski D; Schaffer JL; Nichols DP; Toma CD; Broess M; Bruder SP; Caplan AI
Endocrinology; 1996 Sep; 137(9):3957-68. PubMed ID: 8756572
[TBL] [Abstract][Full Text] [Related]
17. Expression of differentiated function by mineralizing cultures of chicken osteoblasts.
Gerstenfeld LC; Chipman SD; Glowacki J; Lian JB
Dev Biol; 1987 Jul; 122(1):49-60. PubMed ID: 3496252
[TBL] [Abstract][Full Text] [Related]
18. Comparative effects of a novel vitamin D analogue MC-903 and 1,25-dihydroxyvitamin D3 on alkaline phosphatase activity, osteocalcin and DNA synthesis by human osteoblastic cells in culture.
Marie PJ; Connes D; Hott M; Miravet L
Bone; 1990; 11(3):171-9. PubMed ID: 2390375
[TBL] [Abstract][Full Text] [Related]
19. Age-related changes in bone formation, osteoblastic cell proliferation, and differentiation during postnatal osteogenesis in human calvaria.
de Pollak C; Arnaud E; Renier D; Marie PJ
J Cell Biochem; 1997 Jan; 64(1):128-39. PubMed ID: 9015761
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effects of 1,25(OH)2 vitamin D3 on collagen type I, osteopontin, and osteocalcin gene expression in chicken osteoblasts.
Broess M; Riva A; Gerstenfeld LC
J Cell Biochem; 1995 Mar; 57(3):440-51. PubMed ID: 7768979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
